Pharmacokinetics, safety, and efficacy of cedirogant from phase I studies in healthy participants and patients with chronic plaque psoriasis by Mohamed, Mohamed‐Eslam F., Qian, Yuli, D'Cunha, Ronilda, Sligh, Teresa, Ferris, Laura K., Eldred, Ann, Levy, Gweneth F., Hao, Shuai, Gannu, Shashikanth, Rizzo, David G., Liu, Wei, Jazayeri, Sasha, Sofen, Howard, Carcereri De Prati, Roberto

Get full text

Pharmacokinetics, Safety, Tolerability, and Exploratory Efficacy of Upadacitinib in Children with Severe Atopic Dermatitis by Qian, Yuli, Raymundo, Eliza M., Hao, Shuai, Unnebrink, Kristina, Levy, Gweneth F., Teixeira, Henrique D., Chu, Alvina D., Zinn, Zachary A., Paller, Amy S., Liu, Wei, Mohamed, Mohamed-Eslam F.

Get full text

Pharmacokinetics, Safety, and Tolerability of Cedirogant in Healthy Japanese and Chinese Adults by Mohamed, Mohamed‐Eslam F, Qian, Yuli, D'Cunha, Ronilda, Hao, Shuai, Carcereri De Prati, Roberto, Levy, Gweneth F, Hew, Kinjal, Liu, Wei

Get full text

533 - Long-term 5-year safety of upadacitinib in moderate-to-severe atopic dermatitis: an integrated analysis including over 7000 patient-years of exposure by Bunick, Christopher, Chovatiya, Raj, Guttman, Emma, Shahriari, Mona, Boguniewicz, Mark, Gao, Xinghua, Greiwe, Justin, Blauvelt, Andrew, Schuttelaar, Marie L A, Irvine, Alan D, Levy, Gweneth F, Platt, Andrew, Dilley, Deanne, Teixeira, Henrique, Altman, Katherine, Grada, Ayman, Silverberg, Jonathan

Get full text

Contraception Language in Informed Consent Forms: A Survey of Biopharmaceutical Companies by Ng, Eric W, Chiruvolu, Padmaja, Levy, Gweneth F, Allan, Brent R, Wyszynski, Diego F

Get full text

Cedirogant in adults with psoriasis: a phase II, randomized, placebo-controlled clinical trial by Tyring, Stephen, Moore, Angela, Morita, Akimchi, Hong, H Chih-Ho, Song, In-Ho, Eccleston, Jason, Levy, Gweneth, Mohamed, Mohamed-Eslam F, Qian, Yuli, Wu, Tianshuang, Pan, Anqi, Hew, Kinjal, Papp, Kim A

Get full text